Board of Scientific Counselors, National Center for Health Statistics, 79899-79900 [2015-32205]
Download as PDF
Federal Register / Vol. 80, No. 246 / Wednesday, December 23, 2015 / Notices
‘‘FOA DP16–001, Panel D, Pregnancy
Risk Assessment Monitoring System
(PRAMS)’’.
Contact Person for More Information:
Jayalakshmi Raman Ph.D., Scientific
Review Officer, CDC, 4770 Buford
Highway, Mailstop F80, Atlanta,
Georgia 30341, Telephone: (770) 488–
6511, kva5@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
tkelley on DSK3SPTVN1PROD with NOTICES
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2015–32210 Filed 12–22–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4163–18–P
Board of Scientific Counselors,
National Center for Health Statistics
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC), National
Center for Health Statistics (NCHS)
announces the following meeting of the
aforementioned committee.
Times and Dates: 11:00 a.m.–5:30
p.m., EST, January 21, 2016.
8:30 a.m.–1:00 p.m., EST, January 22,
2016.
Place: NCHS Headquarters, 3311
Toledo Road, Hyattsville, Maryland
20782.
Status: This meeting is open to the
public; however, visitors must be
processed in accordance with
established federal policies and
procedures. For foreign nationals or
non-U.S. citizens, pre-approval is
required (please contact Gwen Mustaf,
301–458–4500, glm4@cdc.gov, or
Virginia Cain, vcain@cdc.gov at least 10
days in advance for requirements). All
visitors are required to present a valid
form of picture identification issued by
a state, federal or international
government. As required by the Federal
Property Management Regulations, Title
41, Code of Federal Regulation, Subpart
101–20.301, all persons entering in or
on Federal controlled property and their
packages, briefcases, and other
containers in their immediate
possession are subject to being x-rayed
and inspected. Federal law prohibits the
knowing possession or the causing to be
present of firearms, explosives and other
dangerous weapons and illegal
substances. The meeting room
accommodates approximately 100
people.
Purpose: This committee is charged
with providing advice and making
recommendations to the Secretary,
Department of Health and Human
Services; the Director, CDC; and the
Director, NCHS, regarding the scientific
and technical program goals and
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
Funding Opportunity Announcement
(FOA) DP 16–001, Pregnancy Risk
Assessment Monitoring System
(PRAMS).
Time and Date: 12:00 p.m.–6:00 p.m.,
EST, Panel B, February 2, 2016 (Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘FOA DP16–001, Panel B, Pregnancy
Risk Assessment Monitoring System
(PRAMS)’’.
Contact Person for More Information:
Jayalakshmi Raman, Ph.D., Scientific
Review Officer, CDC, 4770 Buford
Highway, Mailstop F80, Atlanta,
Jkt 238001
[FR Doc. 2015–32208 Filed 12–22–15; 8:45 am]
Centers for Disease Control and
Prevention
[FR Doc. 2015–32209 Filed 12–22–15; 8:45 am]
18:05 Dec 22, 2015
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
VerDate Sep<11>2014
Georgia 30341, Telephone: (770) 488–
6511, kva5@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
79899
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
Funding Opportunity Announcement
(FOA) DP 16–001, Pregnancy Risk
Assessment Monitoring System
(PRAMS).
Times and Dates: 10:00 a.m.–6:00
p.m., EST, Panel A1, January 20–21,
2016 (Closed). 10:00 a.m.–6:00 p.m.,
EST, Panel A2, January 27–28, 2016
(Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘FOA DP16–001, Panel A, Pregnancy
Risk Assessment Monitoring System
(PRAMS)’’.
Contact Person for More Information:
Jayalakshmi Raman, Ph.D., Scientific
Review Officer, CDC, 4770 Buford
Highway, Mailstop F80, Atlanta,
Georgia 30341, Telephone: (770) 488–
6511, kva5@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
PO 00000
Frm 00083
Fmt 4703
Sfmt 4703
E:\FR\FM\23DEN1.SGM
23DEN1
79900
Federal Register / Vol. 80, No. 246 / Wednesday, December 23, 2015 / Notices
objectives, strategies, and priorities of
NCHS.
Matters for Discussion: The agenda
will include:
1. Welcome remarks by the Director,
NCHS
2. Presentation on ICD–10
3. Presentation on Health Interview
Survey Content Redesign
4. Update on Office of Analysis and
Epidemiology
5. Presentation on Web Survey
Requests to make oral presentations
should be submitted in writing to the
contact person listed below. All requests
must contain the name, address,
telephone number, and organizational
affiliation of the presenter.
Written comments should not exceed
five single-spaced typed pages in length
and must be received by December 31,
2015.
The agenda items are subject to
change as priorities dictate.
Contact Person For More Information:
Virginia S. Cain, Ph.D., Director of
Extramural Research, NCHS/CDC, 3311
Toledo Road, Room 7208, Hyattsville,
Maryland 20782, telephone (301) 458–
4500, fax (301) 458–4024.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both CDC and
the Agency for Toxic Substances and
Disease Registry.
PLACE: Hyatt Pittsburgh Airport,
1111 Airport Boulevard, Pittsburgh,
Pennsylvania 15231.
STATUS: The meeting will be closed
to the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
MATTERS FOR DISCUSSION: The
meeting will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘PAR 15–361, NIOSH Centers of
Excellence for Total Worker Health’’.
CONTACT PERSON FOR MORE
INFORMATION: Nina Turner, Ph.D.,
Scientific Review Officer, NIOSH, CDC,
1095 Willowdale Road, Mailstop G905,
Morgantown, West Virginia 26506,
Telephone: (304) 285–5976.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2015–32212 Filed 12–22–15; 8:45 am]
BILLING CODE 4163–18–P
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2015–32205 Filed 12–22–15; 8:45 am]
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
Centers for Disease Control and
Prevention
tkelley on DSK3SPTVN1PROD with NOTICES
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
PAR 15–361, NIOSH Centers of
Excellence for Total Worker Health.
TIMES AND DATES: 8:00 a.m.–5:00
p.m., EST, March 16, 2016 (Closed).
8:00 a.m.–5:00 p.m., EST, March 17,
2016 (Closed).
VerDate Sep<11>2014
18:05 Dec 22, 2015
Jkt 238001
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
Funding Opportunity Announcements
(FOA) IP16–001, Research on the
Epidemiology, Vaccine Effectiveness
and Treatment of Influenza and Other
Respiratory Viruses in Southeast Asia
and the Western Pacific and (FOA)
IP16–002, Annual Estimates of
Influenza Vaccine Effectiveness for
Preventing Medically Attended
Laboratory-Confirmed Influenza in the
United States.
Time and Date: 10:00 a.m.–5:00 p.m.,
EST, February 24–25, 2016 (Closed).
PO 00000
Frm 00084
Fmt 4703
Sfmt 4703
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in section 552b(c)
(4) and (6), title 5 U.S.C., and the
determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Research on the Epidemiology,
Vaccine Effectiveness and Treatment of
Influenza and Other Respiratory Viruses
in Southeast Asia and the Western
Pacific’’, IP16–001 and ‘‘Annual
Estimates of Influenza Vaccine
Effectiveness for Preventing Medically
Attended Laboratory-Confirmed
Influenza in the United States’’, IP16–
002.
Contact Person for More Information:
Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, CDC, 1600
Clifton Road, NE., Mailstop E60,
Atlanta, Georgia 30333, Telephone:
(404) 718–8833.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2015–32206 Filed 12–22–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
Funding Opportunity Announcement
(FOA) CK16–001, Emerging Infections
Sentinel Networks (EISN) Research.
Time and Date: 10:00 a.m.–5:00 p.m.,
January 28, 2016 (Closed).
Place: Teleconference.
E:\FR\FM\23DEN1.SGM
23DEN1
Agencies
[Federal Register Volume 80, Number 246 (Wednesday, December 23, 2015)]
[Notices]
[Pages 79899-79900]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-32205]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Board of Scientific Counselors, National Center for Health
Statistics
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), National Center for Health Statistics (NCHS)
announces the following meeting of the aforementioned committee.
Times and Dates: 11:00 a.m.-5:30 p.m., EST, January 21, 2016.
8:30 a.m.-1:00 p.m., EST, January 22, 2016.
Place: NCHS Headquarters, 3311 Toledo Road, Hyattsville, Maryland
20782.
Status: This meeting is open to the public; however, visitors must
be processed in accordance with established federal policies and
procedures. For foreign nationals or non-U.S. citizens, pre-approval is
required (please contact Gwen Mustaf, 301-458-4500, glm4@cdc.gov, or
Virginia Cain, vcain@cdc.gov at least 10 days in advance for
requirements). All visitors are required to present a valid form of
picture identification issued by a state, federal or international
government. As required by the Federal Property Management Regulations,
Title 41, Code of Federal Regulation, Subpart 101-20.301, all persons
entering in or on Federal controlled property and their packages,
briefcases, and other containers in their immediate possession are
subject to being x-rayed and inspected. Federal law prohibits the
knowing possession or the causing to be present of firearms, explosives
and other dangerous weapons and illegal substances. The meeting room
accommodates approximately 100 people.
Purpose: This committee is charged with providing advice and making
recommendations to the Secretary, Department of Health and Human
Services; the Director, CDC; and the Director, NCHS, regarding the
scientific and technical program goals and
[[Page 79900]]
objectives, strategies, and priorities of NCHS.
Matters for Discussion: The agenda will include:
1. Welcome remarks by the Director, NCHS
2. Presentation on ICD-10
3. Presentation on Health Interview Survey Content Redesign
4. Update on Office of Analysis and Epidemiology
5. Presentation on Web Survey
Requests to make oral presentations should be submitted in writing
to the contact person listed below. All requests must contain the name,
address, telephone number, and organizational affiliation of the
presenter.
Written comments should not exceed five single-spaced typed pages
in length and must be received by December 31, 2015.
The agenda items are subject to change as priorities dictate.
Contact Person For More Information: Virginia S. Cain, Ph.D.,
Director of Extramural Research, NCHS/CDC, 3311 Toledo Road, Room 7208,
Hyattsville, Maryland 20782, telephone (301) 458-4500, fax (301) 458-
4024.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities for
both CDC and the Agency for Toxic Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2015-32205 Filed 12-22-15; 8:45 am]
BILLING CODE 4163-18-P